Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase 3 1

Status

Unknown 4Terminated 3Not yet recruiting 2Completed 1

Sponsor Class

OTHER 3UNKNOWN 1

Study Type

Interventional 4

Sponsor

Cancer Type

Lymphoid 4

Conditions

Stomach Neoplasms 81Colorectal Neoplasms 72Rectal Neoplasms 47Colonic Neoplasms 25Pancreatic Neoplasms 24Neoplasm Metastasis 17Carcinoma, Hepatocellular 17Esophageal Neoplasms 11Cholangiocarcinoma 9Neoplasms 7Lymphoma, Large B-Cell, Diffuse 7Liver Neoplasms 7Biliary Tract Neoplasms 6Colorectal Cancer Metastatic 5Carcinoma, Non-Small-Cell Lung 5Recurrence 4Lymphoma, Extranodal NK-T-Cell 4Gallbladder Neoplasms 4Unspecified Adult Solid Tumor, Protocol Specific 3Locally Advanced Rectal Cancer 3Gastrointestinal Neoplasms 3Esophageal Squamous Cell Carcinoma 3Adenocarcinoma 3Solid Tumors 2Solid Tumor 2Ovarian Neoplasms 2Neurotoxicity Syndromes 2Lymphoma 2Lung Neoplasms 2Locally Advanced Colon Cancer 2

Interventions

pegaspargase 14Etoposide 11Dexamethasone 11Gemcitabine 10spartalizumab 6Oxaliplatin 4sintilimab 3Radiotherapy 3N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamide 3Methotrexate 3Asparaginase 3tislelizumab 2camrelizumab 2Lenalidomide 2Drug Therapy 2Cyclophosphamide 2Cisplatin 2Busulfan 2Azacitidine 2toripalimab 1tofacitinib 1ruxolitinib 1romidepsin 1pembrolizumab 1fludarabine phosphate 1avelumab 1apatinib 1Thalidomide 1Sensitivity and Specificity 1Psychiatric Rehabilitation 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Unknown × Lymphoma, Extranodal NK-T-Cell × Oxaliplatin × Clear all
NCT05254899 2022-02-24

Anti-PD-1 Antibody and P-GEMOX Chemotherapy Combined With Radiotherapy in High-risk Early-Stage ENKTL

ChineseAMS

Phase 2 Unknown
54 enrolled
Lymphoid

Lymphoma, Extranodal NK-T-Cell

NCT02085655 2021-03-15

PEG-ASP+Gemox Regimen and Thalidomide for NK/T Lymphoma

Sun Yat-sen University

Phase 3 Unknown
264 enrolled
Lymphoid

Lymphoma, Extranodal NK-T-Cell

NCT02080234 2016-04-20

Combine GELOX With Concurrent Radiation Therapy for Patients With Stage IE/IIE ENKTL

Sun Yat-sen University

Phase 2 Unknown
40 enrolled
Lymphoid

Lymphoma, Extranodal NK-T-Cell

NCT01921790 2013-08-22

Avastin+ GemAOD As First-Line Treatment in NK/T Cell Lymphoma

Sun Yat-sen University

Phase 2 Unknown
30 enrolled
Lymphoid

Lymphoma, Extranodal NK-T-Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡